Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Biotec Pharmacon ASA

Closing information (x1000 EUR)

Closing information 2019/12 (consolidated) 2018/12 (consolidated) 2017/12 (consolidated)
Turnover 8,557 Less Arrow 7,260 More Arrow 7,394
Financial expenses 82 Less Arrow 0 More Arrow 71
Earnings before taxes -601 Less Arrow -1,379 Less Arrow -2,521
Total assets 7,869 Less Arrow 6,781 Less Arrow 6,269
Current assets 5,941 Less Arrow 5,570 Less Arrow 5,078
Current liabilities 1,862 Less Arrow 1,408 More Arrow 1,714
Equity capital 4,712 More Arrow 5,374 Less Arrow 4,554
- share capital 4,901 Less Arrow 4,819 Less Arrow 4,466
Employees (average) 38 More Arrow 43 More Arrow 44
Shareholders 0 0 0

Financial ratios

Fiscal year 2019/12 (consolidated) 2018/12 (consolidated) 2017/12 (consolidated)
Solvency 59.9% More Arrow 79.3% Less Arrow 72.6%
Turnover per employee 225 Less Arrow 169 Less Arrow 168
Profit as a percentage of turnover -7.0% Less Arrow -19.0% Less Arrow -34.1%
Return on assets (ROA) -6.6% Less Arrow -20.3% Less Arrow -39.1%
Current ratio 319.1% More Arrow 395.6% Less Arrow 296.3%
Return on equity (ROE) -12.8% Less Arrow -25.7% Less Arrow -55.4%
Change turnover 1,174 Less Arrow 6 Less Arrow -594
Change turnover % 16% Less Arrow 0% Less Arrow -7%
Chg. No. of employees -5 More Arrow -1 Less Arrow -2
Chg. No. of employees % -12% More Arrow -2% Less Arrow -4%

Total value of public sale

Fiscal year 2019/12 (consolidated) 2018/12 (consolidated) 2017/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.